LYCIA THERAPEUTICS Trademark
LYCIA THERAPEUTICS is a USPTO trademark filed by Lycia Therapeutics, Inc.. Status: Pending.
Trademark Facts
| Mark | LYCIA THERAPEUTICS |
|---|---|
| Serial Number | 99387673 |
| Status | Pending |
| Filing Date | 2025-09-11 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Lycia Therapeutics, Inc. |
| Attorney of Record | Connie L. Ellerbach |
| Prosecution Events | 15 |
| Latest Event | NOAM on 2026-04-21 |
Goods & Services
Class 005: Pharmaceutical preparations comprising small molecules and antibodies for degrading disease-causing cellular proteins for treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Biological preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Gene therapy products, namely, biological preparations for the treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for use in gene therapy; Biological preparations for use in gene therapy; Viruses for therapeutic purposes, namely, for gene therapy and antivirals
Recent Prosecution Activity
| Date | Document | Type |
|---|---|---|
| 2026-04-21 | Notice of Allowance | ENA |
| 2026-02-24 | OG Publication Confirmation | PB3 |
| 2026-02-18 | Notice of Publication | PB1 |
| 2026-02-18 | Notification of Notice of Publication | EB4 |
| 2026-01-31 | Amendment and Mail Process Complete | AMC |
| 2026-01-30 | Response to Office Action | ROA |
USPTO Refusals on Record
- disclaimer_required